Stockscreener 앱 받기
73.30
1.89%
-1.41
시간 외 거래:
73.30
Edwards Lifesciences Corp 주식(EW)의 최신 뉴스
Principal Financial Group Inc. Sells 23,591 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Pittenger & Anderson Inc. Grows Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
AlphaCentric Advisors LLC Makes New $691,000 Investment in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Baillie Gifford & Co. Buys 498,100 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Has $287,000 Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Ownership Capital B.V. Sells 200,754 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Position Lessened by Chevy Chase Trust Holdings LLC - MarketBeat
CIBC Asset Management Inc Sells 31,973 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Rhumbline Advisers Sells 37,002 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
WD Rutherford LLC Cuts Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Holdings Raised by Empower Advisory Group LLC - MarketBeat
First Merchants Corp Has $773,000 Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Leavell Investment Management Inc. Sells 6,450 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Peering Into Edwards Lifesciences's Recent Short Interest - Benzinga
Edwards Lifesciences Co. (NYSE:EW) Director Steven R. Loranger Sells 5,739 Shares - MarketBeat
Vontobel Holding Ltd. Cuts Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences (NYSE:EW) Stock Rating Lowered by Wolfe Research - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $75.00 - MarketBeat
Scott B. Ullem Sells 11,250 Shares of Edwards Lifesciences Co. (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences' SWOT analysis: stock faces TAVR headwinds, TMTT potential - Investing.com
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MSN
Capital Advisors Inc. OK Decreases Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences (NYSE:EW) Shares Gap Up After Strong Earnings - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Savant Capital LLC - MarketBeat
New York State Teachers Retirement System Sells 42,203 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
26,922 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Asset Planning Inc - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $71.00 at Canaccord Genuity Group - MarketBeat
Edwards Lifesciences (NYSE:EW) Issues FY 2025 Earnings Guidance - MarketBeat
Edwards Lifesciences (NYSE:EW) Releases Q1 2025 Earnings Guidance - MarketBeat
Van ECK Associates Corp Has $12.67 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Morgan Stanley Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Cut to $73.00 by Analysts at Evercore ISI - MarketBeat
Piper Sandler Increases Edwards Lifesciences (NYSE:EW) Price Target to $73.00 - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Q4 2024 Earnings Call Transcript - MSN
Edwards Lifesciences (NYSE:EW) Issues Earnings Results - MarketBeat
AustralianSuper Pty Ltd Has $197.57 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Bogart Wealth LLC Increases Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. Sells 6,500 Shares - MarketBeat
Edwards Lifesciences Director Sells Shares - TradingView
Barclays Increases Edwards Lifesciences (NYSE:EW) Price Target to $90.00 - MarketBeat
Insider Unloading: LESLIE HEISZ STONE Sells Options, Realizes $179K - Benzinga
Ingalls & Snyder LLC Sells 3,463 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Entropy Technologies LP Sells 17,004 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Executives at Edwards Lifesciences Corp Execute Stock Transactions - TradingView
Earnings call transcript: Edwards Lifesciences Q4 2024 beats estimates, stock surges - MSN
Daiwa Adjusts Price Target on Edwards Lifesciences to $77 From $72, Maintains Neutral Rating - Marketscreener.com
1.09%
2.08%
자본화:
|
볼륨(24시간):